News tagged with myeloid leukemia
Some leukemia patients may be able to safely stop treatment
(PhysOrg.com) -- New medical trials suggest some chronic leukemia patients who are in complete remission may be cured by the standard drug used to treat the condition and can safely discontinue its use.
Oct 21, 2010 |
4.2 / 5 (5) |
1
|
Researchers find genetic link to leukemias with an unknown origin
Although leukemia is one of the best studied cancers, the cause of some types is still poorly understood. Now, a newly found mutation in acute myeloid leukemia patients could account for half of the remaining ...
Feb 18, 2010 |
5 / 5 (4) |
0
|
Researchers find drug that inhibits acute leukemia cell growth
Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have discovered how to turn off a certain receptor that promotes the growth of leukemia cells. The pre-clinical study ...
Apr 24, 2009 |
5 / 5 (3) |
1
New evidence of stem cells' pivotal role in cancer shown
Leukemia patients whose cancers express higher levels of genes associated with cancer stem cells have a significantly poorer prognosis than patients with lower levels of the genes, say researchers at the Stanford University ...
Dec 21, 2010 |
5 / 5 (3) |
1
|
Doubling chemo dose helped leukemia patients
(AP) -- Adults with a common form of leukemia had a better chance of remission if they got a double dose of a long-used cancer drug, two new studies found.
Sep 23, 2009 |
5 / 5 (2) |
0
Rituximab and fludarabine produce long-term remissions in CLL
New research shows that a less-toxic combination of a targeted immune-based drug and a chemotherapy drug can produce long-term remissions in some chronic lymphocytic leukemia patients. And it does so without increasing the ...
Feb 25, 2011 |
5 / 5 (2) |
0
Lessons learned from yeast about human leukemia
The trifecta of biological proof is to take a discovery made in a simple model organism like baker's yeast and track down its analogs or homologs in "higher" creatures right up the complexity scale to people, ...
Dec 05, 2011 |
5 / 5 (2) |
0
|
Researchers find two units of umbilical cord blood reduce risk of leukemia recurrence
A new study from the Masonic Cancer Center, University of Minnesota shows that patients who have acute leukemia and are transplanted with two units of umbilical cord blood (UCB) have significantly reduced risk of the disease ...
Nov 13, 2009 |
4.5 / 5 (2) |
1
Study identifies key cause of chronic leukemia progression
Researchers have discovered a key reason why a form of leukemia progresses from its more-treatable chronic phase to a life-threatening phase called blast crisis.
Mar 04, 2010 |
4.5 / 5 (2) |
0
Study describes new tool in the fight against autoimmune diseases, blood cancers
A study led by a Scripps Research Institute scientist describes a new, highly pragmatic approach to the identification of molecules that prevent a specific type of immune cells from attacking their host. The findings add ...
Medicine & Health / Medical research
Nov 30, 2009 |
4 / 5 (2) |
0
Researchers discover key mutation in acute myeloid leukemia
Researchers have discovered mutations in a particular gene that affects the treatment prognosis for some patients with acute myeloid leukemia (AML), an aggressive blood cancer that kills 9,000 Americans annually. ...
Nov 11, 2010 |
3 / 5 (2) |
0
|
A miR boost enables acute leukemia cells to mature
A new study by Ohio State University cancer researchers shows that boosting the level of a molecule called miR-29b in acute myeloid leukemia (AML) cells can reverse gene changes that trap the cells in an immature, ...
Apr 03, 2009 |
5 / 5 (1) |
0
'Misreading' of histone code linked to human cancer
(PhysOrg.com) -- The development of blood from stem cell to fully formed blood cell follows a genetically determined program. When it works properly, blood formation stops when it reaches maturity. But when it doesn’t, genetic ...
Jun 01, 2009 |
5 / 5 (1) |
0
Controversial cancer stem cells offer new direction for treatment (w/ Video)
In a review in Science, a University of Rochester Medical Center researcher sorts out the controversy and promise around a dangerous subtype of cancer cells, known as cancer stem cells, which seem capable of res ...
Jun 25, 2009 |
5 / 5 (1) |
2
Disrupting a destructive duo: Researchers inhibit cancer proteins
A research team led by U of T Mississauga scientists has developed a new way to split up a dangerous pair of cancer proteins, a finding that could ultimately lead to chemotherapy that is more effective and has fewer side ...
Aug 20, 2009 |
5 / 5 (1) |
0
